Amyris Biotechnologies Secures $47.8M Investment from Temasek Holdings
01 April 2010
Temasek Holdings has invested $47.8 million into Amyris Biotechnologies, Inc, a synthetic biology company focused on developing renewable hydrocarbon biofuels. Amyris intends to use these funds to support commercial plant design and construction activities as well as ongoing operations in the US and Brazil.
Temasek Holdings is an Asia investment house headquartered in Singapore.
Amyris has secured $244 million in private funding since inception in 2003, including funding directly into Amyris Biotechnologies and into its subsidiary, Amyris Brasil S.A.
Other Amyris investors include Kleiner Perkins Caufield & Byers, Khosla Ventures, TPG Biotechnology, Votorantim Novos Negocios, Advanced Equities Inc., DAG Ventures, Grupo Cornélio Brennand, Naxos U.K., The Westly Group, and Stratus Group.
Comments